XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.3

Note 12 - Segment Information (Tables)

6 Months Ended

Sep. 30, 2023

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Three Months Ended September 30,								Six Months Ended September 30,
		2023				2022				2023				2022
Revenues:
Sterilization and Disinfection Control		$	17,080			$	16,964			$	33,007			$	31,738
Clinical Genomics			15,549				18,435				28,918				32,940
Biopharmaceutical Development			9,207				12,144				19,096				23,111
Calibration Solutions			11,329				11,206				22,789				21,413
Total revenues (a)		$	53,165			$	58,749			$	103,810			$	109,202
Gross profit:
Sterilization and Disinfection Control		$	12,476			$	12,199			$	24,067			$	22,967
Clinical Genomics			7,727				10,641				14,455				18,490
Biopharmaceutical Development			5,509				7,557				11,942				14,634
Calibration Solutions			6,407				6,007				12,838				11,671
Reportable segment gross profit			32,119				36,404				63,302				67,762
Corporate and Other (b)			(10	)			(18	)			(10	)			(35	)
Gross profit		$	32,109			$	36,386			$	63,292			$	67,727
Reconciling Items:
Operating expense			32,169				32,391				64,016				68,326
Operating (loss) income			(60	)			3,995				(724	)			(599	)
Nonoperating expense, net			1,265				611				1,538				1,429
(Loss) earnings before income taxes		$	(1,325	)		$	3,384			$	(2,262	)		$	(2,028	)

Schedule of Segment Reporting Information, by Inventory Segment [Table Text Block]

		September 30,				March 31,
		2023				2023
Sterilization and Disinfection Control		$	3,889			$	3,492
Clinical Genomics			11,330				13,985
Biopharmaceutical Development			8,541				8,384
Calibration Solutions			9,119				8,781
Total inventories		$	32,879			$	34,642

X

- Definition

A table disclosing the inventory totals for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment inventory reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment inventory.

+ References

No definition available.

+ Details

Name:	mlab_ScheduleOfSegmentReportingInformationByInventorySegmentTableTextBlock
Namespace Prefix:	mlab_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-25

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration